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ABSTRACT
Desquamative inflammatory vaginitis is a poorly understood chronic vaginitis with an unknown etiology. Symptoms of
desquamative inflammatory vaginitis include copious yellowish discharge, vulvovaginal discomfort, and dyspareunia.
Cervical ectropion, the presence of glandular columnar cells on the ectocervix, has not been reported as a cause of
desquamative inflammatory vaginitis. Although cervical ectropion can be a normal clinical finding, it has been reported
to cause leukorrhea, metrorrhagia, dyspareunia, and vulvovaginal irritation. Patients with cervical ectropion and des-
quamative inflammatory vaginitis are frequently misdiagnosed with candidiasis or bacterial vaginosis and repeatedly
treated without resolution of symptoms. We report the case of a 34-year-old woman with a 4-year history of profuse
yellowish discharge and dyspareunia. Upon presentation, her symptoms and laboratory results met the criteria for
desquamative inflammatory vaginitis, but the standard treatments did not provide long-lasting relief. As a last resort,
cryotherapy (cryosurgery) of her cervix was performed for treatment of her cervical ectropion, which provided complete
resolution of her symptoms. Mitchell L, King M, Brillhart H, Goldstein A. Cervical Ectropion May Be a Cause of
Desquamative Inflammatory Vaginitis. Sex Med 2017;X:XXeXX.
Copyright  2017, The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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INTRODUCTION
Desquamative inflammatory vaginitis (DIV) is a poorly
understood chronic inflammatory vaginitis characterized by
copious yellow discharge, vaginal irritation, and dyspareunia.
Examination of the vaginal discharge shows a pH of at least 4.5,
increased polymorphonuclear leukocytes (a ratio of poly-
morphonuclear leukocytes to epithelial cells > 1:1), and many
parabasal cells.1,2 It has been suggested that DIV could be a
severe form of aerobic vaginitis.3 Vaginal cultures can grow group
B Streptococcus species and/or Escherichia coli but are frequently
negative for infectious pathogens.3 It has been reported that up
to 27% of patients with DIV have multiple small erythematous
macules on their ectocervix.2 This finding has been called
“colpitis macularis” or “papular colpitis” and is similar to the
ectocervical findings of a Trichomonas vaginalis infection.2,4 The
diagnosis of DIV is one of exclusion, and other causes of vaginal
inflammation must be ruled out, including T vaginalis, group A
Streptococcus species, erosive lichen planus, atrophic vaginitis,
seminal plasma hypersensitivity, and irritant vaginitis. Although
the etiology of DIV is unknown, it has been postulated that
estrogen deficiency, toxins from Staphylococcus aureus, or an
immunologic process might be the cause.1
Cervical ectropion is the presence of columnar cells on the
ectocervix, which is normally composed of a squamous epithe-
lium. Potential causes of ectropion include adolescent age,
pregnancy, and hormonal contraceptives.5 Some clinicians
believe ectropion could be a normal asymptomatic variant,
whereas others believe it to be correlated with chronic cervicitis.5
The presence of the metaplastic columnar epithelium can man-
ifest a myriad of symptoms including increased vaginal discharge,
leukorrhea, postcoital bleeding, pelvic pain, recurrent cervicitis,
and dyspareunia.5e8 Although the symptoms of ectropion
overlap with DIV, it has not been reported as a cause of DIV.
CASE REPORT
A 34-year-old G2P2002 woman presented to a center
specializing in vulvovaginal disorders for evaluation of a 4-year
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history of persistent vulvovaginal pruritus, irritation, copious
yellowish discharge, and introital dyspareunia. Before her pre-
sentation at the vulvovaginal clinic, she had been seen by mul-
tiple health care providers and had been treated with many
courses of antimycotics and antibiotics including oral flucona-
zole, topical terconazole, topical and oral metronidazole, topical
clindamycin, and topical nystatin. Unfortunately, she had no
long-term improvement of her symptoms with these treatments.
On physical examination she was noted to have erythema and
tenderness of her vulvar vestibule. Examination of her vaginal
vault showed copious purulent vaginal discharge with erythema
and tenderness of the vaginal mucosa, without lesions, ulcera-
tions, erosions, or synechiae. The cervix was non-friable, without
evidence of cervicitis, but cervical ectropion was noted (Figure 1).
The pH of the vaginal discharge was 5.0 and light microscopy
showed many leukocytes and parabasal cells. The vaginal culture
obtained at presentation was negative for pathogens T vaginalis,
Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma
genitalium.
The patient was initially given the diagnosis of DIV, and
because of her failed treatment with clindamycin, she was treated
with intravaginal hydrocortisone as described by Sobel et al.9
Although she initially had complete resolution of her symp-
toms with this treatment, every time she stopped the intravaginal
hydrocortisone, her symptoms recurred. Because the patient
desired definitive treatment for her symptoms, she was offered
cryotherapy (cryosurgery) as a treatment for her ectropion and as
a possible treatment for her DIV.
Using a Graves speculum, the cervix was visualized and an
appropriately sized cryo-tip and nitrous oxide were used to freeze
the ectocervix for 90 seconds (LLCO2 System, Wallach Surgical
Devices, Trumbull, CT, USA).6 Spontaneous thawing occurred
within 60 seconds of the cessation of freezing. An additional
freeze-thaw cycle was performed. The patient tolerated the pro-
cedure and had an uneventful postprocedure recovery.
The patient returned 9 weeks after cryosurgery and reported
significant improvement in her vulvovaginal irritation and
vaginal discharge since the procedure. She reported several weeks
of clear, watery discharge after the procedure, but she denied any
symptoms at the time of follow-up. At physical examination, the
cervix was normal in appearance, with complete resolution of the
ectropion (Figure 2). The vaginal mucosa was no longer
erythematous or tender and there was minimal thin white
discharge. Wet mount examination displayed very few leukocytes
and no parabasal cells. Additional follow-up appointments, up to
34 months after her cryotherapy, confirmed persistent resolution
of her ectropion (Figure 3) and DIV symptoms.
DISCUSSION
DIV is a poorly understood chronic inflammatory vaginitis
that accounts for 8% of patients with chronic vaginitis and is
most common in perimenopausal women, although it is diag-
nosed in a wide age range.1,10 Therefore, our patient is somewhat
unusual because she had DIV at 34 years of age. On average,
women typically have DIV symptoms for 15 to 31 months
before diagnosis.2,9 Although there have been no randomized
Figure 1. Image of patient’s cervix with ectopy before cryotherapy. Figure 2. Image of patient’s cervix 9 weeks after cryotherapy. The
cervical ectropion has resolved.
Figure 3. Image of patient’s cervix 34 months after cryotherapy.
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controlled trials for the treatment of DIV, Sobel et al9 reported
on a case series of 98 women who had high rates of improvement
in symptoms with one of three treatments: vaginal clindamycin
2% cream, vaginal hydrocortisone 10% cream, or cortisone
acetate 25 mg vaginal suppositories.9 They reported that 86% of
women initially had improvement in symptoms with these
treatments, but that 33% of patients had relapse within 6 weeks
of treatment cessation and more than 58% of women required
long-term maintenance therapy to remain asymptomatic. Sobel
et al concluded that DIV is a chronic condition that requires
long-term maintenance therapy in most patients.
The treatment goal for symptomatic ectropion is to destroy
the glandular columnar epithelium, thereby inducing squamous
metaplasia, leading to the resolution of vulvovaginal pruritus,
irritation, yellowish discharge, and dyspareunia. Reported treat-
ment modalities include laser ablation, microwave ablation,
focused ultrasound, platelet-rich plasma injections, herbal ther-
apies, and cryosurgery.6,7,11e13 Most studies have reported very
high cure rates, such as a case series of 50 patients by Mohanty
et al7 who reported a cure rate of 98% in patients who were
treated with cryotherapy.
In conclusion, although it is common to find erythematous
macules on the ectocervix of patients with DIV, the finding of
concurrent cervical ectropion and DIV has not been reported.
Our case illustrates the possibility that some patients with DIV
can have an associated, although not necessarily causative, cer-
vical ectropion. Therefore, given the minimal risks associated
with cryotherapy, clinicians should consider this treatment in
patients with concurrent DIV and ectropion in whom standard
treatments for DIV have failed.
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